Form 4: Avalo Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Jennifer Riley, Chief Strategy Officer of Avalo Therapeutics, Inc., sold 2,655 shares of common stock on August 11, 2026 for $19.59 per share.
Summary
- Open-market sale: disposed of 2,655 Common Stock at $19.59 ($52,012) on August 11, 2026; holds 37,041 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $52,012 of stock on the open market.
Insider Transactions
Jennifer Riley — Officer (Chief Strategy Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-11 | Open-market sale | Common Stock | 2,655 | $20 | $52.0K | 37,041 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-11 | Open-market sale (2,655 shares) |
Keywords
insider transaction, Form 4, AVTX, Avalo Therapeutics, Inc., bearish, Jennifer Riley
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.